Nice post oMandarin. I love the way you think!
When we
Nice post oMandarin. I love the way you think!
When we finally start out accent into the sky high values we all hope to see… I will be ringing that bell often to believe in where we are and where we are headed. Don’t accept a buy out offer and take very little for what could be a huge return in just a short time. In market time on any investment… 3-5 years is a drop in the bucket of time.
We could be there even much quicker with the Block Buster indications. If you like market research and know the market value of each indication we are currently in trial for… you just have to do the math to know just how huge the future could hold. Hundreds of dollars per share will be easy to attain if we get approvals in Cancer and Covid. HIV and Nash will come slower but grow annually every year until the value of Leronlimab is a household name like Bayer Aspirin was in its day. Watching annual growth will be fun to watch. CYDY is that little engine that could… chooooo choooooooo!!!
Why anyone would accept a potential buy out offer when if you waited just a couple of years to be filthy rich is beyond me. It is short sighted and just not the brightest financial move to make.
With Israel closing its borders today to all foreigners from every nation speaks to the new Omicron variant and its potential to become our worst problem to date. Leronlimab needs to escape out of the genie bottle soon and grant us the protection we need to fight this…what seems to be a much more scary variant.
I don’t wish anyone bad health but if a Brazil Covid spike happened now to help progress our trials. The overall value to the rest of the world could be immense in overall lives saved. Getting Leronlimab to the Covid market has been so slow. Time is of the essence for us all. Hopefully our time is soon. Very soon…
7
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Mining's Often Overlooked Obstacle: Land Access In the world of mining, the shallow thrills of striking gold are often overshadowed by the frustrating slog of securing land access. You can have your permits lined up, your finances sorted, and drills humming along, but if you haven’t sweet-talked the folks farming above your visible vein of riches, you could be staring...
Continue Reading
Industry Gears Up for Financial Action Clearly, cannabis businesses are shouting louder than a vendor at a ballgame, demanding more than just the basic chips-and-soda banking service. They’re on the hunt for serious credit facilities, payments, and the traditional financial tools that most sectors take for granted. I mean, check this out: Shield Compliance just dropped...
Continue Reading
Understanding What Constitutes Bad Faith Insurance What does it really mean when an insurer acts in "bad faith"? Well, the legal standard doesn't leave much wiggle room in California. These aren't just bad outcomes; we're talking about conduct that defies what's reasonable under state law. Demián I. Oksenendler, a seasoned bad faith attorney, shed some light on this in a...
Continue Reading
Anticipation Builds for Morphy's Auction Event Morphy's upcoming event on October 4th is all about tapping into the era of revved engines, gleaming gasoline signs, and some history that could put Hollywood tales to shame. The auction isn't just a stroll down memory lane; it features over 650 lots, each a time capsule of America's automotive past. From Al Capone's ritzy...
Continue Reading
Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...
Continue Reading
AbbVie's Game-Changing Atogepant Study When it comes to pushing boundaries in the pharmaceutical world, there's no sitting on the fence. AbbVie's Phase 3 LUNA study results are painting a bright picture for women who suffer from the relentless grip of menstrual migraines. In a world where not a single treatment option has been approved specifically for this condition,...
Continue Reading
Pressure Builds for EquipmentShare Investors If you've thrown some cash into EquipmentShare.com Inc. (NASDAQ: EQPT), it's time to sit up and pay attention. There's smoke on the horizon, and Faruqi & Faruqi, LLP is waving the flag. They've got a securities class action spinning fast, and if you've suffered any losses, September 21, 2026, is a date you don't want to forget....
Continue Reading
Out in Texas, folks facing iron deficiency have a new game-changer coming their way. Drip Gym, the same outfit making waves out in Queens and Long Island, is taking their mobile iron IV therapy clinic straight to Texan doorsteps. No more trotting off to a clinic for iron infusions with this crew rolling into Houston, Dallas, Austin, and San Antonio. What's the Big Deal?...
Continue Reading
Nashville's Notable Deal in Industrial Supply On a muggy September day in Nashville, XLCS Partners announced it was at the helm of a noteworthy transaction—the sale of Signature Engineered Solutions (SES) to AFC Industries. Now, this isn't just another corporate shuffle; it's a calculated move in the gritty world of fastening and engineered solutions. The Nitty-Gritty...
Continue Reading
Award Ceremony Set in the Big Apple In an industry where recognition often feels as transient as a ticker's daily high, the Diversity Action Alliance (DAA) is doing its bit to emphasize the lasting impact individuals can make. On September 16 in New York City, Helio Fred Garcia will be honored with the 2026 Pat Ford Larger Than Life Impact Award at the DAA's Annual...
Continue Reading
Top 5 Most Recently Viewed Articles
Latest Developments Impacting Spirit Airlines (SAVE) Stock Performance Spirit Airlines Inc (SAVE) has experienced notable stock market fluctuations recently, especially after announcing a significant transaction that has captured investor interest. Last week, the budget airline revealed in an SEC filing that it had engaged with GA Telesis to sell 23 A320ceo/A321ceo...
Continue Reading
Inquiry into 23andMe Holding Co. Barrack, Rodos & Bacine has launched an investigation into recent governance changes at 23andMe Holding Co. Their primary focus is the mass resignation of all independent board members, which occurred following CEO Anne Wojcicki's controversial proposal to buy out remaining shares for just 40 cents each. Background of the Situation The CEO...
Continue Reading
Revyve Attracts Significant Investment for Sustainable Protein Dutch food-tech company Revyve has successfully raised nearly €24 million in its latest funding round, which is set to significantly boost its production of yeast proteins aimed at replacing eggs in various food applications. The total capital raised by Revyve now exceeds €40 million, reflecting a robust...
Continue Reading
India Seeks Vital Partnership in Critical Minerals with US India is making significant strides towards securing a critical minerals partnership agreement with the United States. This ambition was highlighted by Piyush Goyal, the country's trade minister, who announced hopes for expanded discussions on a more comprehensive trade pact. Intent Behind the Agreement During a...
Continue Reading
Experience the Thrill of Copy Trading with Toobit In an exciting move, Toobit, a leading player in the world of cryptocurrency exchanges, has launched its Copy Trading Festival. Designed to provide a generous reward pool of 100,000 USDT, this autumn event is an invitation for traders both new and experienced to embark on an enriching trading journey. Why You Should...
Continue Reading